Filing Flows › LifeStance Health Group (LFST) › Q1 2025
LifeStance Health Group (LFST) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 7, 2025
LifeStance Health Group (LFST) reported revenue of $333M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +2% from the quarter before. Operating margin was 0.5%, net earnings $709K (0.2% of revenue).
LifeStance Health Group, Q1 2025: revenue $333M (+11% year over year), operating margin 0.5%, net earnings $709K, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $333M | +2% | +11% |
| Operating profit | $1.6M | — | — |
| Net earnings | $709K | — | — |
| Operating cash flow | −$3.1M | — | — |
What changed
Revenue was $333.0M in Q1 2025, up 11% year over year and up 2% from the previous quarter.
Operating profit was $1.6M, a 0.5% margin (up 6.1 points year over year). Total costs grew 4% against revenue growth of 11%. Net earnings were $709K.
Operating cash flow was −$3.1M. Non-cash charges added back $10.3M of depreciation and amortization and $18.6M of share-based compensation. Working capital and other items used $32.7M. Capital expenditures of $7.2M exceeded it, leaving free cash flow of −$10.3M.
Questions
What was LifeStance Health Group's revenue in the first quarter 2025?
LifeStance Health Group (LFST) reported revenue of $333M for the first quarter 2025 (Q1 2025), +11% from a year earlier and +2% from the quarter before.
Was LifeStance Health Group profitable in the first quarter 2025?
Operating profit was $1.6M (0.5% of revenue) and net earnings $709K.